In The News: Kirk Kerkorian School of Medicine at UNLV

A UNLV study says traffic deaths in Nevada have increased over a decade span.

The number of traffic deaths and fatal crashes statewide has steadily increased since 2013, and there’s an “urgent need” to address the underlying factors, according to ongoing research done by UNLV’s Kirk Kerkorian School of Medicine.

Pharmaceutical company Eli Lilly announced its new weight loss pill has cleared the latest trial. The company says orforglipron can be used to help people with obesity or those overweight with type 2 diabetes. We start by asking him what these drugs do to the body and the effectiveness.

Life-saving treatment gets counted by minutes, even seconds. Here's how medical staff rushed to save lives, at times even risking their own wellbeing.

New guidelines from the American Heart Association and the American College of Cardiology released Thursday suggest you abstain from alcohol and the next time you get your blood pressure checked, expect your medical provider to be a bit more aggressive about high levels, CNN is reporting.

ARC Las Vegas health expert Dr. Marc Kahn broke down a recent study about lithium AND brain function. A study shows for the first time that lithium plays an essential role in normal brain function and can confer resistance to brain aging and Alzheimer’s disease.
Machine learning and deep learning technologies for enhancing the ability to predict bleeding risks is just one of many dramatic changes occurring in the management of hemophilia. Recent advances in artificial intelligence (AI) applications are opening new avenues for the management of hereditary hemophilia (A and B) and acquired hemophilia. AI holds the promise for optimizing treatment regimens and monitoring disease progression with greater precision, according to a review published in the International Journal of Molecular Sciences.

The City of Las Vegas announced a multi-million dollar competition that one city leader said will bring about a crucial next step in the Las Vegas Medical District’s expansion.
In the United States, 12% of adults have taken a glucagon-like peptide 1 (GLP-1) antagonist. The drugs aren’t just popular for weight loss; 62% of adults taking semaglutide or other GLP-1 drugs take them for chronic conditions, such as diabetes and heart disease — and dementia could be added to that list.

Vital entry-level medical professionals such as phlebotomists, medical assistants, certified nursing assistants and nurses are in such high demand in Southern Nevada that accelerated certification and degree programs are plentiful across the Valley. Since some programs can be completed in a matter of weeks, the prospect of starting or changing a career quickly is enticing.

It's a time-honored and somewhat romantic tale: The young fighter who rises from poverty to make a name for themselves. But reality might take some shine off such stories, a new study says.
It’s a time-honored and somewhat romantic tale: The young fighter who rises from poverty to make a name for themselves. But reality might take some shine off such stories, a new study says.